Xiuquan Luo

1.2k total citations
22 papers, 1.0k citations indexed

About

Xiuquan Luo is a scholar working on Molecular Biology, Toxicology and Oncology. According to data from OpenAlex, Xiuquan Luo has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Toxicology and 6 papers in Oncology. Recurrent topics in Xiuquan Luo's work include Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiuquan Luo is often cited by papers focused on Bioactive Compounds and Antitumor Agents (7 papers), Cancer therapeutics and mechanisms (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiuquan Luo collaborates with scholars based in United States and Ireland. Xiuquan Luo's co-authors include M. Saeed Sheikh, David A. Boothman, Zachary Moore, Jinming Gao, Qin He, Gang Huang, Ying Huang, Ying Dong, Erik A. Bey and Huabing Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Xiuquan Luo

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiuquan Luo United States 16 581 204 167 158 148 22 1.0k
Krishnendu Pal United States 20 607 1.0× 182 0.9× 180 1.1× 156 1.0× 280 1.9× 34 1.2k
Adrián Chrastina United States 14 510 0.9× 180 0.9× 161 1.0× 206 1.3× 83 0.6× 22 908
Simone Braig Germany 18 637 1.1× 204 1.0× 211 1.3× 120 0.8× 111 0.8× 34 1.2k
Lihua Du China 16 514 0.9× 426 2.1× 136 0.8× 140 0.9× 237 1.6× 28 1.1k
Qian Guo China 14 710 1.2× 109 0.5× 140 0.8× 68 0.4× 122 0.8× 43 994
Urarika Luesakul Thailand 9 378 0.7× 198 1.0× 160 1.0× 188 1.2× 105 0.7× 9 940
Melissa Millard United States 14 1.1k 1.9× 151 0.7× 228 1.4× 78 0.5× 298 2.0× 18 1.9k
Michael J. Palte United States 11 733 1.3× 155 0.8× 417 2.5× 85 0.5× 132 0.9× 14 1.3k
Mohammad Aminur Rahman United States 18 967 1.7× 318 1.6× 227 1.4× 128 0.8× 229 1.5× 41 1.5k
Robert A. Falconer United Kingdom 19 655 1.1× 157 0.8× 127 0.8× 140 0.9× 222 1.5× 60 1.1k

Countries citing papers authored by Xiuquan Luo

Since Specialization
Citations

This map shows the geographic impact of Xiuquan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuquan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuquan Luo more than expected).

Fields of papers citing papers by Xiuquan Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuquan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuquan Luo. The network helps show where Xiuquan Luo may publish in the future.

Co-authorship network of co-authors of Xiuquan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuquan Luo. A scholar is included among the top collaborators of Xiuquan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuquan Luo. Xiuquan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moon, Seongjun, Do Hoon Kim, Xiuquan Luo, et al.. (2023). A Scalable Engineered Extracellular Matrix Platform to Expand Tumor Cells. Advanced NanoBiomed Research. 3(8). 2 indexed citations
2.
Moon, Seongjun, Do Hoon Kim, Xiuquan Luo, et al.. (2023). A Scalable Engineered Extracellular Matrix Platform to Expand Tumor Cells. SHILAP Revista de lepidopterología. 3(8). 1 indexed citations
3.
Rao, Donald D., Xiuquan Luo, Zhaohui Wang, et al.. (2018). KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex. PLoS ONE. 13(5). e0193644–e0193644. 10 indexed citations
4.
Silvers, Molly A., Stanisław Deja, Robert A. Egnatchik, et al.. (2017). The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism. Journal of Biological Chemistry. 292(44). 18203–18216. 76 indexed citations
5.
Rao, Donald D., Zhaohui Wang, Xiuquan Luo, et al.. (2016). Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma. Molecular Therapy. 24(8). 1412–1422. 37 indexed citations
6.
Barve, Minal, Zhaohui Wang, Padmasini Kumar, et al.. (2015). Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer. Molecular Therapy. 23(6). 1123–1130. 14 indexed citations
7.
Chakrabarti, Gaurab, Zachary Moore, Xiuquan Luo, et al.. (2015). Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. Cancer & Metabolism. 3(1). 12–12. 103 indexed citations
8.
Chakrabarti, Gaurab, Molly A. Silvers, Mariya Ilcheva, et al.. (2015). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Scientific Reports. 5(1). 17066–17066. 49 indexed citations
9.
Luo, Xiuquan, Masatoshi Suzuki, Shanaz A. Ghandhi, Sally A. Amundson, & David A. Boothman. (2014). ATM Regulates Insulin-Like Growth Factor 1-Secretory Clusterin (IGF-1-sCLU) Expression that Protects Cells against Senescence. PLoS ONE. 9(6). e99983–e99983. 34 indexed citations
10.
Ma, Xinpeng, Xiumei Huang, Gang Huang, et al.. (2014). Prodrug Strategy to Achieve Lyophilizable, High Drug Loading Micelle Formulations Through Diester Derivatives of β‐Lapachone. Advanced Healthcare Materials. 3(8). 1210–1216. 30 indexed citations
11.
Huang, Gang, Huabing Chen, Ying Dong, et al.. (2013). Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy. Theranostics. 3(2). 116–126. 269 indexed citations
12.
Luo, Xiuquan, Malina Patel, Longshan Li, Ralph J. DeBerardinis, & David A. Boothman. (2013). Abstract 4614: β-lapachone suppresses glucose metabolism in a NQO1-dependent, tumor-selective manner.. Cancer Research. 73(8_Supplement). 4614–4614. 1 indexed citations
13.
Chen, Renwei, Gary B. Braun, Xiuquan Luo, et al.. (2012). Application of a Proapoptotic Peptide to Intratumorally Spreading Cancer Therapy. Cancer Research. 73(4). 1352–1361. 50 indexed citations
14.
Jiang, Lingyan, Xiuquan Luo, Jingxue Shi, et al.. (2011). PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress. Cancer Biology & Therapy. 11(6). 567–573. 32 indexed citations
15.
Luo, Xiuquan, JoAnne Montalbano, Weixin Jin, et al.. (2010). DOC45, a Novel DNA Damage–Regulated Nucleocytoplasmic ATPase That Is Overexpressed in Multiple Human Malignancies. Molecular Cancer Research. 8(1). 57–66. 38 indexed citations
16.
Luo, Xiuquan, Qin He, Ying Huang, & M. Saeed Sheikh. (2005). Cloning and Characterization of a p53 and DNA Damage Down-regulated Gene PIQ that Codes for a Novel Calmodulin-Binding IQ Motif Protein and Is Up-regulated in Gastrointestinal Cancers. Cancer Research. 65(23). 10725–10733. 25 indexed citations
17.
Luo, Xiuquan, et al.. (2005). Genotoxic and endoplasmic reticulum stresses differentially regulate TRB3 expression. Cancer Biology & Therapy. 4(10). 1063–1067. 52 indexed citations
18.
Luo, Xiuquan, Ying Huang, & M. Saeed Sheikh. (2003). Cloning and characterization of a novel gene PDRG that is differentially regulated by p53 and ultraviolet radiation. Oncogene. 22(46). 7247–7257. 44 indexed citations
19.
He, Qin, Xiuquan Luo, Ying Huang, & M. Saeed Sheikh. (2002). Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. Oncogene. 21(39). 6032–6040. 47 indexed citations
20.
He, Qin, Dong I. Lee, Rong Rong, et al.. (2002). Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene. 21(17). 2623–2633. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krishnendu Pal Breakdown of academic impact, for papers by Adrián Chrastina Breakdown of academic impact, for papers by Simone Braig Breakdown of academic impact, for papers by Lihua Du Breakdown of academic impact, for papers by Qian Guo Breakdown of academic impact, for papers by Urarika Luesakul Breakdown of academic impact, for papers by Melissa Millard Breakdown of academic impact, for papers by Michael J. Palte Breakdown of academic impact, for papers by Mohammad Aminur Rahman Breakdown of academic impact, for papers by Robert A. Falconer
Rankless by CCL
2026